Education & Training
- Fellowship, University of Pittsburgh Medical Center, Magee Womens Hospital, Pittsburgh, PA
- Residency, University of Pittsburgh School of Medicine, Pittsburgh, PA
- MD, West Virigina University School of Medicine, Morgantown, WV
Representative Publications
Taylor SE, Behr S, Cooper KL, Mahdi H, Fabian D, Gallion H, Ueland F, Vargo J, Orr B, Girda E, Courtney-Brooks M, Olawaiye AB, Randall LM, Richardson DL, Sullivan SA, Huang M, Christner SM, Beriwal S, Lin Y, Chauhan A, Chu E, Kohn EC, Kunos C, Ivy SP, Beumer JH. Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemother Pharmacol. 2024 Dec 14;95(1):4. doi: 10.1007/s00280-024-04720-1. PMID: 39673591.
Coffman LG, Orellana TJ, Liu T, Frisbie LG, Normolle D, Griffith K, Uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards RP, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor SE, Buckanovich R. Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer. Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573. PMID: 35972817; PMCID: PMC9675476.
Taylor, SE, Chan, DK, Yang, D, Bruno, T, Lieberman, R, Siddiqui, J, Soong, TR; Coffman, L, Buckanovich, RJ. Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer. Cancers (Basel). 2022 May 5;14(9):2298. doi: 10.3390/cancers14092298. PMID: 35565427; PMCID: PMC9104826.
Taylor SE, Mai PL, Donovan H, Bell SG, Rush SK, Edwards RP, Buckanovich RJ, Smith KJ. Cost-Effectiveness Analysis of Tumor Testing for BRCA Pathogenic Variants in Epithelial Ovarian Cancer. Am J Clin Oncol. 2025 Mar 26. doi: 10.1097/COC.0000000000001187. Epub ahead of print. PMID: 40138181.
Thomas TH, Bender C, Donovan HS, Murray PJ, Taylor S, Rosenzweig M, Sereika SM, Brufsky A, Schenker Y. The feasibility, acceptability, and preliminary efficacy of a self-advocacy serious game for women with advanced breast or gynecologic cancer. Cancer. 2023 May 27. doi: 10.1002/cncr.34887. Epub ahead of print. PMID: 37243943.
Clinical/Research Interest Summary
Clinical Interests/Research Interests
Dr. Taylor’s research interests include targeted and novel treatments of gynecologic cancer, correlated biomarker development for defining personalized cancer therapy, and screening and early detection of gynecologic cancers.